Needham & Company LLC Reaffirms “Buy” Rating for Revolution Medicines (NASDAQ:RVMD)
Needham & Company LLC restated their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Thursday,Benzinga reports. The firm currently has a $57.00 target price on the stock. Several other equities analysts have also recently commented on the company. UBS Group increased their target price on Revolution […]
Needham & Company LLC restated their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Thursday,Benzinga reports. The firm currently has a $57.00 target price on the stock. Several other equities analysts have also recently commented on the company. UBS Group increased their target price on Revolution […]
-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
